Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Irinotecan with Oxaliplatin and Bevacizumab in Advanced Pancreatic Cancer
NCT06782685Phase 2Recruiting
- Start
- Jun 2024
- Primary completion
- Jul 2026
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nanoliposomal irinotecan in pancreatic cancer (PC). Started Jun 2024; status: recruiting.
02
Drugs
nanoliposomal irinotecan
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT06782685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06782685.